AQST — Aquestive Therapeutics Share News
0.000.00%
Last trade - 00:00- $507.07m
- $549.32m
- $44.55m
Aquestive Therapeutics falls as FDA flags issues with oral allergy drug
U.S. RESEARCH ROUNDUP- Blackline, Carmax, Expedia
Aquestive Therapeutics misses Q3 revenue, beats adjusted EBITDA estimates
Brief: Aquestive Therapeutics, Inc. Q3 Income From Operations USD -11.479 Million
Brief: Aquestive Therapeutics Announces Leadership Expansion To Support Growth
U.S. STOCKS ON THE MOVE- Shoe Carnival, Leidos Holdings, copper miners
U.S. STOCKS ON THE MOVE- Gap, Aquestive Therapeutics, Lumentum
Aquestive climbs after US FDA says no advisory panel needed for epinephrine film
Aquestive climbs after US FDA says no advisory panel needed for epinephrine film
Brief: Aquestive Therapeutics Announces That FDA Will Not Require An Advisory Committee Meeting To Discuss New Drug Application For Anaphylm™
Aquestive Therapeutics rises after $85 million stock sale
Brief: Aquestive Therapeutics Announces $75M Strategic Funding Agreement with RTW
Aquestive Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Aquestive Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Aquestive Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Aquestive Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Aquestive Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Aquestive Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Aquestive Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary